Aarti Drugs Limited (NSE:AARTIDRUGS)
India flag India · Delayed Price · Currency is INR
489.85
+0.40 (0.08%)
Aug 4, 2025, 1:30 PM IST

Aarti Drugs Statistics

Total Valuation

Aarti Drugs has a market cap or net worth of INR 44.99 billion. The enterprise value is 50.92 billion.

Market Cap44.99B
Enterprise Value 50.92B

Important Dates

The last earnings date was Thursday, July 24, 2025.

Earnings Date Jul 24, 2025
Ex-Dividend Date Feb 4, 2025

Share Statistics

Current Share Class 91.94M
Shares Outstanding n/a
Shares Change (YoY) -0.78%
Shares Change (QoQ) -0.11%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 35.72M

Valuation Ratios

The trailing PE ratio is 23.83 and the forward PE ratio is 20.14.

PE Ratio 23.83
Forward PE 20.14
PS Ratio 1.86
PB Ratio 3.29
P/TBV Ratio 3.30
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 26.97
EV / Sales 2.10
EV / EBITDA 17.22
EV / EBIT 21.37
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity 0.45
Debt / EBITDA 2.08
Debt / FCF n/a
Interest Coverage 6.67

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) 7.78%
Return on Capital Employed (ROCE) n/a
Revenue Per Employee 22.77M
Profits Per Employee 1.77M
Employee Count1,064
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, Aarti Drugs has paid 301.10 million in taxes.

Income Tax 301.10M
Effective Tax Rate 13.75%

Stock Price Statistics

The stock price has decreased by -4.76% in the last 52 weeks. The beta is 0.41, so Aarti Drugs's price volatility has been lower than the market average.

Beta (5Y) 0.41
52-Week Price Change -4.76%
50-Day Moving Average 481.84
200-Day Moving Average 433.70
Relative Strength Index (RSI) 44.72
Average Volume (20 Days) 829,830

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Aarti Drugs had revenue of INR 24.22 billion and earned 1.89 billion in profits. Earnings per share was 20.64.

Revenue24.22B
Gross Profit 8.65B
Operating Income 2.38B
Pretax Income 2.19B
Net Income 1.89B
EBITDA 2.96B
EBIT 2.38B
Earnings Per Share (EPS) 20.64
Full Income Statement

Balance Sheet

The company has 226.10 million in cash and 6.15 billion in debt, giving a net cash position of -5.92 billion.

Cash & Cash Equivalents 226.10M
Total Debt 6.15B
Net Cash -5.92B
Net Cash Per Share n/a
Equity (Book Value) 13.69B
Book Value Per Share 149.84
Working Capital n/a
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 35.73%, with operating and profit margins of 9.84% and 7.80%.

Gross Margin 35.73%
Operating Margin 9.84%
Pretax Margin 9.04%
Profit Margin 7.80%
EBITDA Margin 12.21%
EBIT Margin 9.84%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 0.20%.

Dividend Per Share 1.00
Dividend Yield 0.20%
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 0.78%
Shareholder Yield 0.99%
Earnings Yield 4.20%
FCF Yield n/a
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on September 30, 2020. It was a forward split with a ratio of 4.

Last Split Date Sep 30, 2020
Split Type Forward
Split Ratio 4

Scores

Altman Z-Score n/a
Piotroski F-Score 2